Mr Abram Melkyzedeck Suhardiman was appointed as the Executive Director of the Company on 26 April 2019 and was re-designated from Chief Operating Officer to Deputy Chief Executive Officer (“Deputy CEO”) of the Company and its subsidiaries (the “Group”) on 10 February 2020. Mr Suhardiman was re-designated to the position of Executive Vice Chairman on 9 March 2023. He was last re-appointed on 27 April 2022 as an Executive Director of the Company.
Prior to joining Healthway Medical Corporation Limited, Mr Suhardiman served as the Vice President at Nuvest Capital, Singapore. He has also worked at The Abraaj Group and Citibank where he was part of the investment team in Southeast Asia. Mr Suhardiman holds a Bachelor of Science in Business Administration from the University of Southern California, Los Angeles, United States of America and a Masters in Finance from Hult International Business School, San Francisco, United States of America.